MONOMETHYLVALINE COMPOUNDS HAVING PHENYLALANINE SIDE-CHAIN MODIFICATIONS AT THE C-TERMINUS
申请人:Seattle Genetics, Inc.
公开号:US20130123465A1
公开(公告)日:2013-05-16
Auristatin peptide analogs of MeVal-Val-Dil-Dap-Phe (MMAF) are provided having C-terminal phenylalanine residue side chain replacements or modifications which are provided alone or attached to ligands through various linkers. The related conjugates can target specific cell types to provide therapeutic benefit.
提供了MeVal-Val-Dil-Dap-Phe(MMAF)的Auristatin肽类类似物,其具有C-末端苯丙氨酸残基侧链替换或修饰,可单独提供或通过各种连接剂连接到配体上。相关的结合物可以定向特定的细胞类型,以提供治疗效益。